Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Vadim Alexandre | Liam Gascoigne-Cohen
3 pages
Hemogenyx Pharma (HEMO.L): Approval of Hu-PHEC cell therapy patent | e-therapeutics (ETX.L): Board restructuring
Companies: HemoGenyx Pharmaceuticals Plc
Companies: SYN EPP CSSG ARC CRCL HEMO BUCE TM1
